320 related articles for article (PubMed ID: 15812959)
21. The two meanings of how and the gene patenting debate.
Evans JH
Am J Bioeth; 2002; 2(3):26-8. PubMed ID: 12230851
[No Abstract] [Full Text] [Related]
22. Sequence patents are not the issue.
Robertson JA
Am J Bioeth; 2002; 2(3):22-3. PubMed ID: 12230848
[No Abstract] [Full Text] [Related]
23. Religious voices in biotechnology: the case of gene patenting.
Hanson MJ
Genetic Resour; 1999; 12(1-2):5-22. PubMed ID: 12962106
[TBL] [Abstract][Full Text] [Related]
24. Owning the secret of life: biotechnology and property rights revisited.
Yelpaala K
McGeorge Law Rev; 2000; 32(1):111-219. PubMed ID: 15709267
[No Abstract] [Full Text] [Related]
25. Bioprospecting, genetic patenting and indigenous populations: challenges under a restructured information commons.
Faye DJ
J World Intellect Prop; 2004 May; 7(3):401-28. PubMed ID: 16755699
[No Abstract] [Full Text] [Related]
26. Patenting basic research: myths and realities.
Kirschenbaum SR
Nat Neurosci; 2002 Nov; 5 Suppl():1025-7. PubMed ID: 12403976
[No Abstract] [Full Text] [Related]
27. Patent reform prompts intellectual tug-of-war.
Nature; 2005 Oct; 437(7063):1230-1. PubMed ID: 16251923
[No Abstract] [Full Text] [Related]
28. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
Resnik DB; DeVille KA
Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
[No Abstract] [Full Text] [Related]
29. Brave new industry, that has such patents in it! Reflections on the economic consequences of patenting DNA.
Cockburn IM
Adv Genet; 2003; 50():385-98; discussion 507-10. PubMed ID: 14714701
[No Abstract] [Full Text] [Related]
30. The scope of utility in the twenty-first century: new guidance for gene-related patents.
Summers TM
Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071
[No Abstract] [Full Text] [Related]
31. Patenting human life and the rebirth of the Thirteenth Amendment.
McDonald ES
Notre Dame Law Rev; 2003 May; 78(4):1359-87. PubMed ID: 15237536
[No Abstract] [Full Text] [Related]
32. European Directive on the Legal Protection of Biotechnological Inventions: scope, status and controversies in a nutshell.
Hakki MM
E Law; 2004 Mar; 11(1):E4. PubMed ID: 16903025
[No Abstract] [Full Text] [Related]
33. Patenting of human embryonic stem cells in Europe.
Treichel P
Biotechnol J; 2009 Apr; 4(4):462-4. PubMed ID: 19370720
[No Abstract] [Full Text] [Related]
34. How can you patent genes?
Eisenberg RS
Am J Bioeth; 2002; 2(3):3-11. PubMed ID: 12230840
[TBL] [Abstract][Full Text] [Related]
35. Intellectual property and products of nature.
Sagoff M
Am J Bioeth; 2002; 2(3):12-3. PubMed ID: 12230841
[No Abstract] [Full Text] [Related]
36. Biotech in post-TRIPS India.
Ramani SV; Pradhan P; Ravi M
Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
[No Abstract] [Full Text] [Related]
37. Sharing information is preferable to patenting.
Macilwain C
Nature; 2013 Jun; 498(7454):273. PubMed ID: 23783592
[No Abstract] [Full Text] [Related]
38. Intellectual property in higher life forms: the patent system and controversial technologies.
Merges RP
MD Law Rev; 1988; 47(4):1051-75. PubMed ID: 16514761
[No Abstract] [Full Text] [Related]
39. Genes and patent policy: rethinking intellectual property rights.
Andrews LB
Nat Rev Genet; 2002 Oct; 3(10):803-8. PubMed ID: 12360238
[TBL] [Abstract][Full Text] [Related]
40. The case for genomic patenting.
Poste G
Nature; 1995 Dec; 378(6557):534-6. PubMed ID: 8524376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
